NCT02494284

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation : STAMP-DES Trial

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 364 (actual)
• Sponsor: CHEOL WHAN LEE, M.D., Ph.D · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare short-term (6-month Dual Anti Platelet Therapy(DAPT) followed by clopidogrel monotherapy) vs. standard long-term dual antiplatelet strategies (24-month DAPT followed by aspirin monotherapy) on clinically relevant bleeding complications (Bleeding Academic Research Consortium(BARC) type 2, 3, or 5)31 in patients after zotarolimus-eluting stent implantation.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DRUG	Clopidogrel	6-month DAPT followed by clopidogrel monotherapy
DRUG	Aspirin plus clopidogrel	standard long-term dual antiplatelet strategies (24-month DAPT followed by aspirin monotherapy)

Timeline

• Start date: 2015-12-22
• Primary completion: 2017-02-13
• Completion: 2017-02-13
• First posted: 2015-07-10
• Last updated: 2017-02-23

Locations

12 sites across 1 country: South Korea